This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dickson, S. E. Articles by Fraser, H. M. Search for Related Content PubMed PubMed Citation Articles by Dickson, S. E. Articles by Fraser, H. M.

Inhibition of Early Luteal Angiogenesis by Gonadotropin-Releasing Hormone Antagonist Treatment in the Primate

Medical Research Council Human Reproductive Sciences Unit, Centre for Reproductive Biology, Edinburgh, EH3 9ET, United Kingdom

Address correspondence and requests for reprints to: Sarah E. Dickson, Medical Research Council Human Reproductive Sciences Unit, Centre for Reproductive Biology, 37 Chalmers Street, Edinburgh, EH3 9ET, United Kingdom. E-mail: s.dickson{at}ed-rbu.mrc.ac.uk

Angiogenesis during luteal development is essential for normal lutein cell function, but the control of this process and the relationships between the steroidogenic and endothelial cells have still to be elucidated. The aim of this study was to: 1) quantify endothelial cell proliferation throughout the luteal phase of the marmoset ovulatory cycle; 2) determine the effect of gonadotropin withdrawal using GnRH antagonist treatment on the early luteal phase angiogenesis peak; and 3) describe the resultant morphological changes in the corpus luteum (CL). Ovaries were collected during the early, mid-, and late luteal phase, and changes in angiogenic activity were determined by quantification of bromodeoxyuridine incorporation. Animals were treated with a GnRH antagonist, on luteal days 1 and 2, and ovaries were collected on day 3. A proliferation index was obtained by counting the number of bromodeoxyuridine immunopositive cells in luteal sections. Cell proliferation was maximal in the early luteal phase and fell significantly in the mid- and late CL. GnRH antagonist treatment reduced the early luteal phase proliferation peak by 90%, suppressed plasma progesterone, and severely disrupted lutein cell morphology. These results demonstrate that the intense angiogenesis in the early primate CL is dependent on gonadotropin stimulation of lutein cells.

This article has been cited by other articles:

				R S Robinson, A J Hammond, G E Mann, and M G Hunter A novel physiological culture system that mimics luteal angiogenesis Reproduction, March 1, 2008; 135(3): 405 - 413. [Abstract] [Full Text] [PDF]

				A. Silvestri and H. M Fraser Oestrogen and progesterone receptors in the marmoset endometrium: changes during the ovulatory cycle, early pregnancy and after inhibition of vascular endothelial growth factor, GnRH or ovariectomy Reproduction, August 1, 2007; 134(2): 341 - 353. [Abstract] [Full Text] [PDF]

				L. S. Sleer and C. C. Taylor Platelet-Derived Growth Factors and Receptors in the Rat Corpus Luteum: Localization and Identification of an Effect on Luteogenesis Biol Reprod, March 1, 2007; 76(3): 391 - 400. [Abstract] [Full Text] [PDF]

				H. M Fraser, H. Wilson, C. Wulff, J. S Rudge, and S. J Wiegand Administration of vascular endothelial growth factor Trap during the 'post-angiogenic' period of the luteal phase causes rapid functional luteolysis and selective endothelial cell death in the marmoset. Reproduction, October 1, 2006; 132(4): 589 - 600. [Abstract] [Full Text] [PDF]

				J Aguilar, H M Fraser, H Wilson, E Clutton, D J Shaw, and E D Watson Temporal relationship between proliferating and apoptotic hormone-producing and endothelial cells in the equine corpus luteum Reproduction, July 1, 2006; 132(1): 111 - 118. [Abstract] [Full Text] [PDF]

				H. M. Fraser, H. Wilson, K. D. Morris, I. Swanston, and S. J. Wiegand Vascular Endothelial Growth Factor Trap Suppresses Ovarian Function at All Stages of the Luteal Phase in the Macaque J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5811 - 5818. [Abstract] [Full Text] [PDF]

				P D Taylor, S G Hillier, and H M Fraser Effects of GnRH antagonist treatment on follicular development and angiogenesis in the primate ovary J. Endocrinol., October 1, 2004; 183(1): 1 - 17. [Abstract] [Full Text] [PDF]

				H. E. Turner, A. L. Harris, S. Melmed, and J. A. H. Wass Angiogenesis in Endocrine Tumors Endocr. Rev., October 1, 2003; 24(5): 600 - 632. [Abstract] [Full Text] [PDF]

				P. Kohen, O. Castro, A. Palomino, A. Munoz, L. K. Christenson, W. Sierralta, P. Carvallo, J. F. Strauss III, and L. Devoto The Steroidogenic Response and Corpus Luteum Expression of the Steroidogenic Acute Regulatory Protein after Human Chorionic Gonadotropin Administration at Different Times in the Human Luteal Phase J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3421 - 3430. [Abstract] [Full Text] [PDF]

				A. J. Rowe, K. D. Morris, R. Bicknell, and H. M. Fraser Angiogenesis in the Corpus Luteum of Early Pregnancy in the Marmoset and the Effects of Vascular Endothelial Growth Factor Immunoneutralization on Establishment of Pregnancy Biol Reprod, October 1, 2002; 67(4): 1180 - 1188. [Abstract] [Full Text] [PDF]

				C. Wulff, S. E. Dickson, W. C. Duncan, and H. M. Fraser Angiogenesis in the human corpus luteum: simulated early pregnancy by HCG treatment is associated with both angiogenesis and vessel stabilization Hum. Reprod., December 1, 2001; 16(12): 2515 - 2524. [Abstract] [Full Text] [PDF]

				C. Wulff, H. Wilson, J. S. Rudge, S. J. Wiegand, S. F. Lunn, and H. M. Fraser Luteal Angiogenesis: Prevention and Intervention by Treatment with Vascular Endothelial Growth Factor TrapA40 J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3377 - 3386. [Abstract] [Full Text] [PDF]